Lombard Odier Asset Management (Switzerland)’s NextCure NXTC Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,941	Closed	-$2.44M	–	323
2021 Q4	$2.44M	Buy	33,941 +2,871	+9%	+$240K	0.16%	86
2021 Q3	$2.51M	Buy	31,070 +2,896	+10%	+$254K	0.16%	97
2021 Q2	$2.71M	Buy	28,174 +4,956	+21%	+$507K	0.14%	101
2021 Q1	$2.79M	Buy	+23,218	New	+$3.36M	0.19%	91

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s NXTC Position: Q1 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of NextCure (NXTC) in Q1 2022, closing a stake of 33,941 shares — an estimated $2.44M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in NXTC in Q1 2021 and held it in 4 quarters. The position peaked at $2.79M in Q1 2021. 59 funds tracked by Wall St. Rank hold NXTC as of Q1 2022.

Lombard Odier Asset Management (Switzerland) reported no remaining NextCure position as of Q1 2022 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 33,941 NextCure shares in Q1 2022, an estimated $2.44M.
Lombard Odier Asset Management (Switzerland) first reported a position in NextCure in Q1 2021 and held it in 4 quarters.
Lombard Odier Asset Management (Switzerland)'s NextCure position peaked at $2.79M in Q1 2021.
59 funds tracked by Wall St. Rank held NextCure as of Q1 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.